UpNano receives capital boost for further advancing high-end 2PP 3D printers, materials, and services. Vienna, Austria 17. October 2024 – UpNano GmbH (Vienna, Austria) today announced the completion of its EUR 7M Series A round co-led by aws Gründungsfonds, Novacapital and IGO Innovation GmbH. The funds raised will allow UpNano to accelerate the development of […]
Research at Karl Landsteiner University of Health Sciences demonstrates synergistic effect of inhibiting two regulatory proteins in multiple myeloma. Krems (Austria), 16. October 2024: The simultaneous inhibition of the transcription factors Myc and JunB could represent a pioneering therapeutic option for the treatment of multiple myeloma (MM), the second most common type of blood cancer. […]
European study of sex-related differences in the type and treatment of heart valve diseases published, with physician from Karl Landsteiner University of Health Sciences as corresponding author. Krems (Austria), 25. September 2024: In Europe, incidences of severe native valvular heart disease (VHD) and their treatment vary between men and women. This is the key finding […]
IMC Krems plays a leading role in the establishment of innovative cell-based test systems for the identification of biomarkers. Krems, Austria, 13. August 2024: A research project led by the IMC University of Applied Sciences Krems has just been successfully completed and now provides an excellent basis for further projects: The team led by Prof. […]
UpNano co-developed a revolutionary manufacturing process for fused silica parts in the mm-range using 2PP technology. Vienna, Austria 23. July 2024 – UpNano GmbH (Vienna, Austria) has co-developed a novel manufacturing process for 3D-printed fused quartz objects. This innovative technology enables the production of high-precision shaped parts in the mm and cm-range. The process is […]
Study at the Karl Landsteiner University of Health Sciences uncovers unknown interaction between leukemic cells and immune cells. Potential biomarkers for future immunotherapies found. Krems (Austria), 16 July 2024: The protein STAT3 helps the immune system to recognise leukemic cells. This interaction, which is important for future immunotherapies, is now understood in detail thanks to […]
IMC Krems participates in groundbreaking study that includes data from the third-party perspective of social media users Krems, Austria, 09. July 2024: Consumers using social media respond to interactions between micro-influencers and the hospitality industry when the latter two act in a “collaborative” setting (free food/accomodation vs. mentioning the hospitality business on social media). Interestingly, […]
Joint research by BOKU Tulln and IMC University of Applied Sciences Krems shows great potential in the recovery of valuable materials from electronic waste. Up to 85% recovery of rare earths achieved in the laboratory. Krems, Austria, 11. June 2024: A research collaboration between BOKU Tulln and IMC University of Applied Sciences Krems is using […]
he protein STAT3? has a positive influence on the course of acute myeloid leukaemia (AML) and could serve as a prognostic marker in the future. These are the outstanding results of a cancer research study at the Karl Landsteiner University of Health Sciences (KL Krems). In the work now published in Cell Death & Disease, an international research team succeeded in identifying the previously unknown effect of the protein on interferon-dependent signalling pathways.
AI identifies mutations. Karl Landsteiner University of Health Sciences once again sets standards with machine learning methods Krems (Austria), 16. May 2024: Machine learning (ML) methods can quickly and accurately diagnose mutations in gliomas – primary brain tumours. This is shown by a recent study by Karl Landsteiner University of Health Sciences (KL Krems). In […]